Decentralized Clinical Trials

FDA Issues Proposed Guidance for the use of Digital Health Technology in Clinical Investigations

FDA Issues Proposed Guidance for the use of Digital Health Technology in Clinical Investigations

In recent years, a multitude of Digital Health Technologies (DHTs) have emerged, many with the ability to solve some of the biggest problems in clinical trials. However, uptake has been slow.  Now, proposed new Food and Drug Administration (FDA) guidelines could change all that by finally giving sponsors, contract manufacturing organizations (CMOs), and contract research…

Read More

Addressing Medication Adherence in Decentralized Clinical Trials

Adherence in Decentralized Clinical Trials

Adherence monitoring can minimize variability and maximize engagement in DCTs Decentralized clinical trials (DCT) are growing in popularity, thanks to their ability to tear down many of the long-standing barriers to robust medical research. And while this new model has some challenges of its own, focusing on adherence can help tackle them head-on. COVID-19 accelerated…

Read More